Trade NRSN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
NeuroSense Therapeutics Ltd. (NRSN) is trading at US$6.35, down 5.51% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$14.21M. Over the past 52 weeks, NRSN has traded between US$5.00 and US$26.64. On Syfe you can trade NRSN with $0 commission and add it to your watchlist.
| Previous close | US$6.72 |
|---|---|
| Market cap | US$14.21M |
| 52-week range | US$5.00 – US$26.64 |
| Volume | 7.22K |
| Exchange | US |
Add to Watchlist
Set Price Alert
NeuroSense Therapeutics Ltd.
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Year: 2021
NeuroSense Says Phase 2b Trial of PrimeC in Amyotrophic Lateral Sclerosis Meets Primary Endpoint
Jun 29, 2:00 PM · MT Newswires
NeuroSense Therapeutics Gets South Korean Patent for ALS Drug Candidate PrimeC
Jun 11, 1:29 PM · MT Newswires
Sector Update: Healthcare Stocks Rise Tuesday Afternoon
Jun 9, 5:24 PM · MT Newswires
NeuroSense Therapeutics Receives Japanese Patent for PrimeC to Treat ALS
Jun 9, 1:39 PM · MT Newswires
NeuroSense Therapeutics Ltd. (NRSN) stock is trading at US$6.35, -5.51% from the previous close of US$6.72.
The market cap for NeuroSense Therapeutics Ltd. (NRSN) stock is approximately US$14.21M.
The 52-week high for NeuroSense Therapeutics Ltd. (NRSN) stock is US$26.64.
The 52-week low for NeuroSense Therapeutics Ltd. (NRSN) stock is US$5.00.
NeuroSense Therapeutics Ltd. (NRSN) does not currently pay a dividend.
Stay on top of NRSN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
